Venous stent preclinical testing typically uses large animal models. We created two models of infrarenal inferior vena cava (IVC) stenting to study patency, flow rate, wall shear stress, and endothelial coverage over the stents in a microsurgery rodent model.
Methods:
In Group 1, Sprague-Dawley rats underwent IVC stenting. Patency was measured by ultrasonography immediately postoperatively (POD-0) and at postoperative day 1 (POD-1). Stents underwent histological analysis up to 21 days postimplantation. Group 2 stented rats received periprocedural anticoagulation (enoxaparin 6 mg/kg SC) and were harvested to evaluate stent coverage using scanning electron microscopy (SEM). En face immunofluorescence (IF) staining was performed in Group 3. Human samples from stent occlusions were collected in the endovascular suite and compared with the animal histological findings.
Results:
In Group 1, 65% of the stented animals (13/20) were patent POD-0, increasing to 85% (17/20) by POD-1. Histologically, in-stent restenosis (ISR) was 6.2 ± 3.8%, and residual thrombosis (RT) was 32.01 ± 23.12% of the IVC total luminal stent area (LSA). These animals’ pathological processes are similar to those in humans. The mean IVC vein wall thickness (VWT) was 80.18 ± 13.14 μm. In Group 2, all animals were patent (21/21) postimplantation and remained patent in POD-1. IF demonstrated stent coverage with CD31+ endothelial cells. Total stent endothelialization by SEM reached 69.53 ± 14.84% at 7 days and increased to 91.51 ± 11.23% at 21 days.
Conclusion:
Quantifying rat venous stent patency and endothelialization via histology and microscopy revealed complete patency with anticoagulation and pathological occlusions (RT, ISR) when withholding anticoagulation. This rodent model will facilitate the preclinical testing of future venous stents.
TangALakhterVZackCJ, et al. Contemporary nationwide trends and in-hospital outcomes of adjunctive stenting in patients undergoing catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord2021; 9: 62–72.e1.
2.
DivakaranSMeissnerMHKohiMP, et al. Utilization of and outcomes associated with intravascular ultrasound during deep venous stent placement among Medicare beneficiaries. J Vasc Interv Radiol2022; 33: 1476–1484.e2.
BreenK.Role of venous stenting for venous thromboembolism. Hematology Am Soc Hematol Educ Program2020; 2020: 606–611.
5.
DeitelzweigSBJohnsonBHLinJ, et al. Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections. Am J Hematol2011; 86: 217–220.
6.
GrosseSDNelsonRENyarkoKA, et al. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res2016; 137: 3–10.
BadeshaASBlackSAKhanG, et al. A meta-analysis of the medium- to long-term outcomes in patients with chronic deep venous disease treated with dedicated venous stents. J Vasc Surg Venous Lymphat Disord2024; 12: 101722.
9.
MassiIZamboniP.What are the ideal characteristics of a venous stent?Veins and Lymphatics. Published online Jun 18, 2021. DOI: 10.4081/vl.2021.9739.
10.
SmithSButtsHOwensJ, et al. Outcomes following stenting for symptomatic chronic iliofemoral venous stenosis – a comparison of three stent types. J Vasc Surg Venous Lymphat Disord2025; 13: 102208.
11.
ChickJFBAbramowitzSDOsherML, et al. Radiographic findings of distressed venous stents and inferior vena cava filters: Clinical implications. AJR Am J Roentgenol2017; 209: 1150–1157.
12.
DabirDFeisstAThomasD, et al. Physical properties of venous stents: An experimental comparison. Cardiovasc Intervent Radiol2018; 41: 942–950.
13.
JayarajAFullerRRajuS, et al. In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord2022; 10: 42–51.
14.
SaleemTRajuS.An overview of in-stent restenosis in iliofemoral venous stents. J Vasc Surg Venous Lymphat Disord2022; 10: 492–503.e2.
15.
WilliamsDMNicklasJMObiA, et al. Pathologic characteristics of human venous in-stent stenosis and stent occlusion. J Vasc Surg Venous Lymphat Disord2023; 11: 109–118.e2.
16.
KishoreSKhajaMSThornburgB, et al. Antithrombotic therapy after venous interventions: AJR Expert Panel Narrative Review. AJR Am J Roentgenol2022; 219: 175–187.
17.
BritoLAChandrasekharSLittleSR, et al. Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis. Biomed Eng Online2010; 9: 56.
18.
Van BelleETioFOCouffinhalT, et al. Stent endothelialization: Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation1997; 95: 438–448.
19.
Van BeusekomHMMErtaşGSoropO, et al. The GenousTM endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv2012; 79: 231–242.
20.
RanjanAKKumarUHardikarAA, et al. Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS One2009; 4: e7718.
21.
WenLQiuHLiS, et al. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing. Acta Biomater2024; 179: 371–384.
22.
LimEVarcoeR.Current status of and future prospects for drug-eluting stents and scaffolds in infrapopliteal arteries. J Clin Med2024; 13: 1757.
23.
PaulAEliasCBShum-TimD, et al. Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization. Sci Rep2013; 3: 2366.
24.
Percie Du SertNAhluwaliaAAlamS, et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol2020; 18: e3000411.
25.
MorenoOLukeCEClayA, et al. Rodent inferior vena cava venoplasty balloon model. J Vis Exp2024; e66820.
26.
WrobleskiSKFarrisDMDiazJA, et al. Mouse complete stasis model of inferior vena cava thrombosis. J Vis Exp2011; (52): 2738.
27.
VlachopoulosCO’RourkeMNicholsWW.McDonald’s blood flow in arteries: Theoretical, experimental and clinical principles. 6th ed.CRC Press, 2011.
28.
KatritsisDKaiktsisLChaniotisA, et al. Wall shear stress: Theoretical considerations and methods of measurement. Prog Cardiovasc Dis2007; 49: 307–329.
29.
Jun KangYYeomELeeS-J. A microfluidic device for simultaneous measurement of viscosity and flow rate of blood in a complex fluidic network. Biomicrofluidics2013; 7: 054111.
30.
Van BeusekomHMWhelanDMvan de PlasM, et al. A practical and rapid method of histological processing for examination of coronary arteries containing metallic stents. Cardiovasc Pathol1996; 5: 69–76.
31.
QuentinTPoppeABärK, et al. A novel method for processing resin-embedded specimens with metal implants for immunohistochemical labelling. Acta Histochem2009; 111: 538–542.
32.
RippsteinPBlackMKBoivinM, et al. Comparison of processing and sectioning methodologies for arteries containing metallic stents. J Histochem Cytochem2006; 54: 673–681.
33.
LangeveldBVan GilstWHTioRA, et al. Angiotensin-(1–7) attenuates neointimal formation after stent implantation in the rat. Hypertension2005; 45: 138–141.
34.
HenkePKWakefieldTWKadellAM, et al. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res2001; 99: 84–91.
35.
VarmaMRMoaveniDMDewyerNA, et al. Deep vein thrombosis resolution is not accelerated with increased neovascularization. J Vasc Surg2004; 40: 536–542.
36.
DowlingARLukeCECaiQ, et al. Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis. JVS Vasc Sci2022; 3: 246–255.
37.
KessingerCWKimJWHenkePK, et al. Statins improve the resolution of established murine venous thrombosis: Reductions in thrombus burden and vein wall scarring. PLoS One2015; 10: e0116621.
38.
MukhamadiyarovRABogdanovLAGlushkovaTV, et al. EMbedding and backscattered scanning electron microscopy: A detailed protocol for the whole-specimen, high-resolution analysis of cardiovascular tissues. Front Cardiovasc Med2021; 8: 739549.
39.
De PradoAPPérez-MartínezCCuellas-RamónC, et al. Time course of reendothelialization of stents in a normal coronary swine model: Characterization and quantification. Vet Pathol2011; 48: 1109–1117.
40.
AndriesLJBrutsaertDLSysSU.Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res1998; 82: 195–203.
41.
YanWLiTYinT, et al. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation. Theranostics2020; 10: 10712–10728.
42.
DiazJAObiATMyersDDJr, et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol2012; 32: 556–562.
43.
DiazJASahaPCooleyB, et al. Choosing a mouse model of venous thrombosis. Arterioscler Thromb Vasc Biol2019; 39: 311–318.
44.
SahaPAndiaMEModaraiB, et al. Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation2013; 128: 729–736.
45.
Stein-MerlobAFKessingerCWErdemSS, et al. Blood accessibility to fibrin in venous thrombosis is thrombus age-dependent and predicts fibrinolytic efficacy: An in vivo fibrin molecular imaging study. Theranostics2015; 5: 1317–1327.
46.
OguriNGiTNakamuraE, et al. Expression of fibroblast activation protein-α in human deep vein thrombosis. Thromb Res2024; 241: 109075.
47.
ZhaoYLilesAObiAT, et al. Histopathology of iliofemoral vein in-stent occlusion in postthrombotic syndrome: Findings from endovascular thrombectomy. Vasc Med2026; 31: 81–89.
48.
KhajaMSObiATSharmaAM, et al. Optimal medical therapy following deep venous interventions: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol2022; 33: 78–85.
49.
McQueenAEscuerJAggarwalA, et al. Do we really understand how drug eluted from stents modulates arterial healing?Int J Pharm2021; 601: 120575.
50.
BarbatiMEBechter-HuglBThomisS, et al. Evaluation of safety and performance of a new prototype self-expandable nitinol venous stent in an ovine model. JVS Vasc Sci2023; 4: 100113.
51.
ZhangXWangZGuoJ.An experimental study of inferior vena caval stent in canine. Chin Med J (Engl)1999; 112: 816–821.
52.
ZhouJMayLLiaoP, et alInferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol2009; 29: 863–869.
53.
TanabeYMitaraiTIshibashiY, et al. Endothelialization of a venous stent at 1 month post implantation: First-in-human angioscopic assessment. J Invasive Cardiol2020; 32: E248.
54.
LiuCChenDLiZ, et al. Adventitial collagen cross-linking by glutaraldehyde reinforcing human saphenous vein—Implication for coronary artery bypass grafting. Braz J Cardiovasc Surg2022; 37: 439–446.
55.
BarboriakJJVan HornDLPintarK, et al. Scanning electron microscope study of human veins and aorta-coronary artery vein grafts. J Thorac Cardiovasc Surg1976; 71: 673–679.
56.
CheHJiangJLiuH, et al. Preliminary report of a new type of braided vein stent in animals. Phlebology2019; 34: 246–256.
57.
FinnAVNakazawaGJonerM, et al. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol2007; 27: 1500–1510.
58.
JonerMFinnAVFarbA, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol2006; 48: 193–202.
59.
NgJBourantasCVToriiR, et al. Local hemodynamic forces after stenting: Implications on restenosis and thrombosis. Arterioscler Thromb Vasc Biol2017; 37: 2231–2242.
60.
PlassCASabdyusheva-LitschauerIBernhartA, et al. Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents. JACC Cardiovasc Interv2012; 5: 741–751.
61.
KipshidzeNDangasGTsapenkoM, et al. Role of the endothelium in modulating neointimal formation. J Am Coll Cardiol2004; 44: 733–739.
62.
SinghraoSKNicholsonKCreanS.Informed choices for challenging specimens when choosing methacrylate resin systems for histology. Microsc Res Tech2012; 75: 576–585.
63.
VirmaniR.Drug eluting stents: Are human and animal studies comparable?Heart2003; 89: 133–138.
64.
GaoLChaherNSerralhaJC, et al. Molecular MRI of collagen enables evaluation of fibrosis and therapeutic response in venous thrombosis. Circ Cardiovasc Imaging2026; 19: e018784.
65.
HaraTTrueloveJTawakolA, et al. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus. Circulation2014; 130: 1044–1052.
66.
MarstonWAChinubhaiAKaoS, et al. In vivo evaluation of safety and performance of a nitinol venous stent in an ovine iliac venous model. J Vasc Surg Venous Lymphat Disord2016; 4: 73–79.
67.
LiaoJLAbramowitzSDChoiC, et al. Lower extremity woven and nonwoven venous stent morphology and luminal changes. J Vasc Surg Venous Lymphat Disord2024; 12: 101893.
68.
TengSZhuZLiY, et al. A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model. Front Pharmacol2023; 14: 1159779.
69.
MuraseSSuzukiYYamaguchiT, et al. The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent. Catheter Cardiovasc Interv2014; 83: 412–417.
70.
GoriTPolimeniAIndolfiC, et al. Predictors of stent thrombosis and their implications for clinical practice. Nat Rev Cardiol2019; 16: 243–256.
71.
DilettiRGarcia-GarciaHMBourantasCV, et al. Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: The Svelte Coronary Stent Integrated Delivery System first-in-man trial. EuroIntervention2013; 9: 125–134.
72.
LinWZhangHZhangW, et al. In vivo degradation and endothelialization of an iron bioresorbable scaffold. Bioact Mater2021; 6: 1028–1039.
73.
HahnDLeeDHyunW, et al. Faster smooth muscle cell coverage in ultrathin-strut drug-eluting stent leads to earlier re-endothelialization. Front Bioeng Biotechnol2023; 11: 1207858.
74.
JinnouchiHOtsukaFSatoY, et al. Healthy strut coverage after coronary stent implantation: An ex vivo human autopsy study. Circ Cardiovasc Interv2020; 13: e008869.
75.
ZunPSNarracottAJChiastraC, et al. Location-specific comparison between a 3D in-stent restenosis model and micro-CT and histology data from porcine in vivo experiments. Cardiovasc Eng Tech2019; 10: 568–582.
76.
MusickKMCoffeyACIrazoquiPP.Sensor to detect endothelialization on an active coronary stent. Biomed Eng Online2010; 9: 67.
77.
SheridanWSWetterlingFTestaniJM, et al. Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation. Eur J Heart Fail2023; 25: 754–763.
78.
WuZZhouZBianC, et al. In vivo evaluation of safety and performance of a tapered nitinol venous stent with inclined proximal end in an ovine iliac venous model. Sci Rep2024; 14: 7669.
79.
OliverAACorteseJOgnardJ, et al. Magnetic capture of autologous mesenchymal stem cells promotes the rapid endothelialization of peripheral venous stents in rabbits. Acta Biomater2026; 211: 188–203.
80.
CornelissenAGuoLFernandezR, et al. Endothelial recovery in bare metal stents and drug-eluting stents on a single-cell level. Arterioscler Thromb Vasc Biol2021; 41: 2277–2292.
81.
HuYJiaHCuiHSongJ.Application of spatial omics in the cardiovascular system. Research (Wash D C)2025; 8: 0628.
82.
LorentzenLGHansenGMIversenKK, et al. Proteomic characterization of atherosclerotic lesions in situ using percutaneous coronary intervention angioplasty balloons—Brief report. Arterioscler Thromb Vasc Biol2022; 42: 857–864.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
